NOVA MENTIS LIFE SCIENCE CORP To Carry Out 1-for-5 Reverse Stock Split On November 8th, 2024

Moomoo NewsNov 6 19:40 ET

Psyched: LSD For Major Depression, Canada's Large Scale Psilocybin Macrodose Trial, Treatments For Autism Spectrum Disorder And Multiple Sclerosis And More

BenzingaApr 24, 2023 15:58 ET

Psychedelics And The Spectrum: Groundbreaking Study Details How One Firm Approaches Autism

BenzingaApr 20, 2023 09:04 ET

Health Canada Grants Section 56 Exemption: Phase 2 Trial On Psilocybin For Leading Autism Cause

Benzinga Real-time NewsFeb 14, 2023 13:37 ET

Nova Mentis Life Science Appoints Executive Chairman

Seeking AlphaJan 18, 2023 08:56 ET

First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval

Benzinga Real-time NewsDec 27, 2022 12:48 ET